Chi‐Wei Chen
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer therapeutics and mechanisms 5
- DNA Repair Mechanisms 4
- RNA modifications and cancer 4
- RNA Interference and Gene Delivery 3
- Synthesis and bioactivity of alkaloids 2
- Oncology 8
- PARP inhibition in cancer therapy 3
- Co-authors
- Te‐Chang Lee (7 shared papers)Wenge Zhu (5 shared papers)Katherine M. Aird (5 shared papers)Tsann-Long Su (3 shared papers)Yunxiao Meng (4 shared papers)Rajesh Kakadiya (3 shared papers)Anamik Shah (2 shared papers)Ting‐Chao Chou (2 shared papers)
- Journals
- Oncogene (2 papers)Cancer Research (2 papers)Translational Oncology (2 papers)The Journal of Cell Biology (2 papers)Cancer Letters (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Chi‐Wei Chen
22 papers receiving 529 citations
Peers
Comparison fields: 5 of 79
- Geriatrics and Gerontology 27
- Cancer Research 89
- Toxicology 17
- Molecular Biology 295
- Organic Chemistry 115
Countries citing papers authored by Chi‐Wei Chen
This map shows the geographic impact of Chi‐Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Wei Chen more than expected).
Fields of papers citing papers by Chi‐Wei Chen
This network shows the impact of papers produced by Chi‐Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Wei Chen. The network helps show where Chi‐Wei Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Wei Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 67 | |
| 2 | 2018 | 58 | |
| 3 | 2018 | 52 | |
| 4 | 2015 | 45 | |
| 5 | 2019 | 44 | |
| 6 | 2021 | 43 | |
| 7 | 2019 | 39 | |
| 8 | 2012 | 36 | |
| 9 | 2022 | 25 | |
| 10 | 2001 | 25 | |
| 11 | 2016 | 20 | |
| 12 | 2019 | 17 | |
| 13 | 2022 | 11 | |
| 14 | 2020 | 10 | |
| 15 | 2023 | 10 | |
| 16 | 2021 | 10 | |
| 17 | Comparison of clinical outcomes following guided tissue regeneration treatment with a polylactic acid barrier or a collagen membrane. | 2010 | 9 |
| 18 | 2023 | 5 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 3 |
About Chi‐Wei Chen
Chi‐Wei Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Organic Chemistry and Biomedical Engineering, having authored 29 papers that have together received 534 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), DNA Repair Mechanisms (4 papers), RNA modifications and cancer (4 papers), RNA Interference and Gene Delivery (3 papers), PARP inhibition in cancer therapy (3 papers), Synthesis and Reactivity of Heterocycles (2 papers), Synthesis and pharmacology of benzodiazepine derivatives (2 papers) and Synthesis and bioactivity of alkaloids (2 papers). The work is most often cited by research in Geriatrics and Gerontology (27 citations), Cancer Research (89 citations), Toxicology (17 citations), Molecular Biology (295 citations) and Organic Chemistry (115 citations). Chi‐Wei Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Te‐Chang Lee, Wenge Zhu, Katherine M. Aird, Tsann-Long Su, Yunxiao Meng, Rajesh Kakadiya, Anamik Shah, Ting‐Chao Chou, Kelly E. Leon and Tung‐Hu Tsai. Their work appears in journals such as Oncogene, Cancer Research, Translational Oncology, The Journal of Cell Biology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.